000			01719nas#a2200433#a#4500
001			vtls000984146
003			NLI
005			20210627100759.0
008			120214s1980 dcuan p c f0 0eng
039		9	_y201202141716 _zDatasoft
040			_aNLI _beng _cDatasoft_FOD _eAACR2
041	0		_aeng
044			_adcu
050			_aRS91 _b.A66
082	0	4	_a615.1
110	1		_aUnited States. _bDepartment of Health and Human Services _9707894
245	1	0	_aApproved prescription drug products with therapeutic equivalence evaluations / _cUnited States Department of Health and Human Services
246	0		_aApproved Rx drug products
260			_aWashington, D.C. : _bU. S. Dept. of Health and Human Services, Food and Drug Administration, Bureau of Drugs, _c1980
300			_a10 p. ; _c28 cm.
310			_aAnnual
362	1		_a1980-1984
550			_aVols. for 1980-1981 issued by Food and Drug Administration, Bureau of Drugs; 1982-1984 by National Center for Drugs and Biologics.
610	2	0	_aUnited States. _bFood and Drug Administration. _bBureau of Drugs _9736175
650		0	_aDrugs _xTherapeutic equivalency _9694312
650		0	_aDrugs _xBioavailability _9694313
650		0	_aDrugs _vCatalogs _9694314
650		0	_aPharmaceutical services insurance _9694315
650		0	_aMedical care _9699952
650		0	_aCatalogs, Drug _9694317
650		0	_aTherapeutic Equivalency _9694318
650		0	_aPrescriptions, Drug _9694319
710	1		_aUnited States. _bFood and Drug Administration. _bBureau of Drugs _9736175
710	2		_aNational Center for Drugs and Biologics (U.S.) _9736176
887			_a
901			_aAD 84177 _b18.08.10
902			_aU.S 615.1 Un 3
999			_aVIRTUA40 _c804591 _d804591
942			_2ddc _cBKS